Abstract
The StarClose device (Abbott Vascular Devices; Abbott Laboratories, Redwood City, CA) utilizes an externally placed Nitinol clip to achieve arterial closure following femoral artery puncture. The objectives of this study were to assess the efficacy and complications of the StarClose device in patients undergoing interventional radiological procedures. Preprocedural clotting status, pulse and blood pressure, severity of vessel calcification, sheath size, and time to deployment were recorded. Postdeployment complications immediately postprocedure, at 1 h, at 2 h, and at 1 week were recorded. A duplex scan was performed in the first 10 patients to assess any immediate vascular complications. Deployments were successful in 96% achieving immediate hemostasis. Mean deployment time was 48 s. There were no major complications. The StarClose device was found to have a high technical and clinical efficacy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lehmann KG, Heath-Lange SJ, Ferris ST (1999) Randomized comparison of hemostasis techniques after invasive cardiovascular procedures. Am Heart J 138(6; Pt 1):1118–1125
Bogart MA (1995) Time to hemostasis: |a comparison of manual versus mechanical compression of the femoral artery. Am J Crit Care 4(2):149–156
Thore V, Berder V, Houplon P, et al. (2001) Role of manual compression time and bed rest duration on the occurrence of femoral bleeding complications after sheath retrieval following 4fr left-sided cardiac catheterization. J Interv Cardiol 14(1):7–10
Tagney J, Lackie D (2005) Bed-rest post-femoral arterial sheath removal: What is safe practice? A clinical audit. Nurs Crit Care 10(4):167–173
Eggebrecht H, Haude M, Woertgen U, et al. (2002) Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients. Catheter Cardiovasc Interv 57(4):486–495
Silber S (2000) Ten years of arterial closure devices: a critical analysis of their use after PTCA. Z Kardiol 89(5):383–389
Koreny M, Riedmuller E, Nikfardjam M, et al. (2004) Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA 291:350–357
Hoffer EK, Bloch RD (2003) Percutaneous arterial closure devices. J Vasc Interv Radiol 14:865–886
Sanborn TA, Gibbs HH, Brinker JA, et al. (1993) A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty. J Am Coll Cardiol 22:1273–1279
Chamberlin JR, Lardi AB, McKeever LS, et al. (1999) Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Catheter Cardiovasc Interv 47:143–147
Kahn ZM, Kumar M, Hollander G, et al. (2002) Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Cathet Cardiovasc Interv 55:8–13
Ward SR, Casale P, Raymond R, et al. (1998) Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Invest. Am J Cardiol 81:569–572
Abando A, Hood D, Weaver F, et al. (2004) The use of the Angioseal device for femoral artery closure. J Vasc Surg 40(2):287–290
Belenky A, Aranovich D, Greif F, et al. (2007) Use of a collagen-based device for closure of low brachial artery punctures. Cardiovasc Interv Radiol 30(2):273–275
Starnes BW, O’Donnell SD, Gillespie DL, et al. (2003) Percutaneous arterial closure in peripheral vascular disease: a prospective randomized evaluation of the Perclose device. J Vasc Surg 38(2):263–271
Juergens CP, Leung DY, Crozier JA, et al. (2004) Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention. Catheter Cardiovasc Interv 63(2):166–170
Abbot Laboratories (2005) StarClose vascular closure system, instructions for use. Abbott Vascular Devices, Redwood City, CA, p 2
Castelli P, Caronno R, Piffaretti G, et al. (2006) Incidence of vascular injuries after use of the Angio-Seal closure device following endovascular procedures in a single center. World J Surg 30(3):280–284
Mukhopadhyay K, Puckett MA, Roobottom CA (2005) Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol 56(3):409–412
Kirchhof C, Schickel S, Schmidt-Lucke C, et al. (2002) Local vascular complications after use of the hemostatic puncture closure device Angio-Seal. Vasa 31(2):101–106
Wille J, Vos JA, Overtoom TT, et al. (2006) Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg 20(2):278–281
Carey D, Martin JR, Moore CA, et al. (2001) Complications of femoral artery closure devices. Catheter Cardiovasc Interv 52(1):3–7, discussion 8
Jang JJ, Kim M, Gray B, et al. (2006) Claudication secondary to Perclose use after percutaneous procedures. Catheter Cardiovasc Interv 67(5):687–695
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imam, A., Carter, R.M.S., Phillips-Hughes, J. et al. StarClose Vascular Closure Device: Prospective Study on 222 Deployments in an Interventional Radiology Practice. Cardiovasc Intervent Radiol 30, 738–742 (2007). https://doi.org/10.1007/s00270-007-9079-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-007-9079-5